China NMPA Product Recall - Human ABO blood typing reverse typing red blood cell kit; irregular antibody screening red blood cell reagent (indirect anti-human globulin method) ID-DiaCell I-II-III Asia
China NMPA product recall for Human ABO blood typing reverse typing red blood cell kit; irregular antibody screening red blood cell reagent (indirect anti-human globulin method) ID-DiaCell I-II-III Asia by Bio-Ray Life Sciences (Shanghai) Co., Ltd. published January 18, 2021. Recall level: Level 3 Recall. Bio-Rad Life Sciences (Shanghai) Co., Ltd. initiated a Class III voluntary recall of two in-vitro di
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Human ABO blood typing reverse typing red blood cell kit; irregular antibody screening red blood cell reagent (indirect anti-human globulin method) ID-DiaCell I-II-III Asia by Bio-Ray Life Sciences (Shanghai) Co., Ltd. published January 18, 2021. Recall level: Level 3 Recall. Bio-Rad Life Sciences (Shanghai) Co., Ltd. initiated a Class III voluntary recall of two in-vitro di
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox